morphiceptin has been researched along with tyrosine in 2 studies
| Studies (morphiceptin) | Trials (morphiceptin) | Recent Studies (post-2010) (morphiceptin) | Studies (tyrosine) | Trials (tyrosine) | Recent Studies (post-2010) (tyrosine) |
|---|---|---|---|---|---|
| 139 | 0 | 12 | 44,273 | 846 | 8,225 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheinberg, DA; Wellner, D; Xu, Y | 1 |
| do-Rego, JC; Fichna, J; Gach, K; Janecka, A; Janecki, T; Kluczyk, A; Perlikowska, R; Piekielna, J; Toth, G; Wyrębska, A | 1 |
2 other study(ies) available for morphiceptin and tyrosine
| Article | Year |
|---|---|
Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Bradykinin; CD13 Antigens; Cell Line; Cell Membrane; Endorphins; Enkephalin, Leucine; Humans; In Vitro Techniques; Kinetics; Molecular Sequence Data; Protease Inhibitors; Substance P; Swine; Tyrosine | 1995 |
Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs.
Topics: Amino Acid Sequence; Animals; Drug Interactions; Endorphins; Male; Mice; Oligopeptides; Opioid Peptides; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Structure-Activity Relationship; Tyrosine | 2011 |